ArticleInvestigational new drugs2018

Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose.

Aurelia H M de Vries Schultink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.